Process for synthesizing macrocyclic chelates |
| The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process ... |
|
Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| I claim: 1. A method for producing a 1:1 protein:anitbody tioether-linked immunoconjugate as a ... |
|
Compositions for photodynamic therapy |
| I claim: 1. A pharmaceutical composition useful for photodynamic therapy which composition contains,... |
|
Amplifier molecules for enhancement of diagnosis and therapy |
| As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a ... |
|
Peptide-containing polyethylene glycol derivatives and application thereof |
| OF THE PREFERRED EMBODIMENTS The present invention will hereinafter be explained in more detail. T... |
|
Modified HIL-6 |
| OF THE INVENTION Described below is the chemical modification with PEG of at least one amino group ... |
|
Construction of geometrical objects from polynucleotides |
| By means of the present invention, DNA, RNA and similar polymers may be produced by synthesizing a ... |
|
Starburst conjugates |
| In its broadest aspect, the present invention is directed to polymer conjugate materials comprising ... |
|
Intermediates for providing functional groups on the 5' end of oligonucleotides |
| We claim: 1. A partially protected alcohol of the formula: ##STR10## wherein Y.sup.1 is selected ... |
|
Antiviral polynucleotide conjugates |
| OF THE INVENTION The present invention provides polynucleotide conjugates characterized by the ... |
|
|
Substrate for detection of mammalian 5-C-DNA methyltransferase
| Details |
Inventors: Sufrin, Janice R.; Christman, Judith K.; Marasco, Jr., Canio J.; Sheikhnejad, Gholamreza;
Assignee: Health Research, Inc. (Buffalo, NY)
Primary Examiner: Robinson; Douglas W.
Assistant Examiner: Wai; Thanda
Attorney, Agent or Firm: Dunn; Michael L.
A substrate selective for detection of mammalian 5-C-DNA methyltransferase in the presence of bacterial 5-C-DNA methyltransferase, said substrate comprising oligomeric DNA which contains at least one 5-methylcytosine residue, and at least one cytosine or 5-fluorocytosine residue, each of which are followed in linkage to a guanine residue. The invention also includes a method for measuring the presence of mammalian 5-C-DNA methyltransferase which comprises contacting a sample containing 5-C-DNA methyl transferase with the substrate and also includes a method for inhibiting mammalian 5-C-DNA methyltransferase which comprises contacting a sample containing 5-C-DNA methyl transferase with the substrate. |
|
DETAILED DESCRIPTION OF THE INVENTION "Oligomeric DNA" or ODN, as used herein, means a DNA having from 10 to 75 "purine or pyrimidine bases" connected in a series of nucleotides which are deoxyribonucleotides or analogs of deoxyribonucleotides with chemically modified sugars or linkages between sugars. Purine or pyrimidine bases as used herein mean adenine (A), cytosine (C), guanine (G), thymine (T), and analogs of C (5-methyl-cytosine, 5-fluoro-cytosine, 5-bromo-cytosine, etc. ) that have been chemically modified so as to continue to be chemically acceptable into a synthetic chain of deoxyribonucleic acid or deoxyribonucleic acid analogs. "5-C-DNA methyl transferase" means DNA 5-cytosine methyl transferase for methylation of cytosine to form a 5-methyl-2'-deoxycytosine residue in DNA. To obtain DNA analogs which are highly specific for mammalian DNA methyltransferase, we have artificially constructed ODN analogs of DNA which contain CG sequences that have the intrinsic potential to be recognized and methylated by DNA methyltransferases. In general, we have chosen ODN constructs which are 24 bases in length, or 24mers, but our invention can also apply to ODNs that are shorter and/or longer than 24 bases in length e. g. , 10 to 75 and preferably 12 to 50 bases in length. We have examined the activity of these ODNs as substrates for DNA methyltransferase, and have identified single-stranded as well as double-stranded constructs of DNA which are excellent substrates of DNA methyltransferase. Four examples of DNA constructs are shown in Table 1. They are labeled Sense (S), Antisense (AS), Methylated Antisense 1 (M1) and Methylated Antisense 2 (M2). The mammalian DNA methyltransferase substrate activity of these 4 single-stranded ODNs is shown in Table 2. It can be seen that M2 has exceptional substrate activity, especially in comparison with S and AS, which were designed to have an optimal number of potentially methylatable CG sites available. In contrast to the remarkable substrate activity of M
|
| Related patents |
|
|
Vinyl ethers of nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the racemic and diasteromeric mixtures of these isomers which may exist for ...
|
|
|
Nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the racemic and diasteromeric mixtures of these isomers which may exist for ...
|
|
|
Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
To accomplish those objectives, the present invention provides hydrophobic muiticomponent heparin conjugates in which heparin is coupled with macromolecules and ...
|
|
|
Gas permeable bioreactor and method of use
OF THE PREFERRED EMBODIMENTS Like numbered apparatus elements in FIGS. 1-11 are the same. Referring to the drawings, FIG. 1 is a cross-sectional side view of a ...
|
|
|
Method for treating diseases of the inner ear using adamantane derivatives
OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or conceivable in many cases of diseases of the inner ear. Preferably, adamantane ...
|
|
|
Polyalkylene oxide-containing urethane polyols with sulphonic acid groups
What is claimed is: 1. Sulphonic acid group-containing polyalkylene oxide-containing urethane polyols corresponding to the formula: ##STR16## wherein X represents an NH....
|
|
|
Herpes treatment
I claim: 1. A method for the control of herpes virus infections in man which comprises contacting the herpes lesions, topically or by injection, with a dose of L-lysine L...
|
|
|
Dense star polymers and dendrimers
OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is covalently bonded to at least one core branch, preferably at least two, ...
|
|
|
Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is group U of ...
|
|
|
Oligonucleotide derivatives and production thereof
Gist In view of the state of the art as described above, the present inventors have developed an immobilized oligonucleotide which is useful in purification of nucleic ...
|
|
|